Christine Yuan Huang, MD

Dr. Christine Yuan HUANG is the Founder and CEO of Quantum Life Limited and the Technology Transfer Director of Hong Kong Quantum AI Lab (jointly by University of Hong Kong and California Institute of Technology). She is also the Managing Director of HK Longevity Medical Centre, focusing on providing end-to-end precision longevity medical technology solutions to improve health-span. Dr. Huang has vast experience in the biotechnology and longevity field and shares her professional insights as a Venture Partner of LongeVC.

Before founding Quantum Life, Dr. Huang was selected as one of Forbes China 2020 “30 Under 30 (Healthcare and Science)” for developing a liquid-biopsy technology for ovarian cancer, and she was awarded as the “Pioneer of Genome Technology ”in 2024. Dr. Huang lead the invention of the global first “AI-enabled precision healthy longevity medical system” which awards as the Gold Medal in the 50th Geneva International Invention Exhibition in 2025. Recognized for her outstanding achievements in AI medicine, she was the only Chinese entrepreneur invited to deeply involved in the formulation of the first national-level framework agreement of the AI medical system in Abu Dhabi. And she was named one of Fortune China Most Powerful Women of 2025 for her global impact.

Dr. Huang began her career as a clinical research physician in the Department of Neurology at Queen Mary Hospital, Hong Kong. In 2022, she was elected as the Fellow of the Royal Society of Medicine in the UK, and the Fellow of the European Society of Preventive Medicine in 2024. She is also a member of the Advisory Board of Wing Wah Charity Foundation Hong Kong, and a columnist of Forbes China. Dr. Huang was elected as a Fellow of Guangzhou Youth Federation in November 2022. Dr. Huang obtained Doctor of Medicine from the Southern Medical University and Master of Public Health from the University of Hong Kong, Li Ka Shing Faculty of Medicine.